May 7, 2024
Juliane Nguyen, PhD, professor and vice chair of pharmacoengineering and molecular pharmaceuticals at the UNC Eshelman School of Pharmacy, and Janelle Arthur, PhD, associate professor of microbiology and immunology at the UNC School of Medicine, have engineered a probiotic yeast to treat inflammatory bowel disease in animals.
April 10, 2024
A new study in the lab of Bryan Roth, MD, PhD, at the UNC School of Medicine, helps us better understand how we perceive bitter taste on a chemical level. The findings may lead to the development of drugs that targeting taste receptors.
April 5, 2024
John P. Vavalle, MD, MHS, FACC, and Matthew A. Cavender, MD, MPH, FACC, interventional cardiologists and their collaborative team in the Structural Heart Disease Program at UNC, have performed their first transcatheter tricuspid valve replacement in the clinical setting, a revolutionary treatment for patients living with a common type of heart valve disease.
April 5, 2024
The University of North Carolina at Chapel Hill was one of four academic medical centers on the study, which shows that an intervention program developed by the American Academy of Pediatrics can dramatically reduce injuries in young children.
March 20, 2024
A new study, led by Ana T. Nogueira, PhD, Rebekah Layton, PhD, at the UNC School of Medicine and collaborators from the NIH Broadening Experiences in Scientific Training (NIH BEST) consortium, examined career confidence in graduate and postdoctoral trainees and explored how to better support international trainees across a diverse array of career paths.
March 18, 2024
A landmark study, led by Yen-Yu Ian Shih, PhD, professor of neurology and associate director of UNC’s Biomedical Research Imaging Center, could alter how researchers interpret results from functional magnetic resonance imaging.
March 15, 2024
New research by the lab of Jessica Thaxton, PhD, MsCR, in the Department of Cell Biology and Physiology at the UNC School of Medicine and colleagues in the Immunotherapy Group at the UNC Lineberger Comprehensive Cancer Center, has unveiled new clues behind T-cell metabolism that could enhance immunotherapies that rely on T cells to fight cancer.
March 6, 2024
In this new Vital Signs series, we feature graduate student Max Hockenberry, who performs research in the labs of Wes Legant, PhD, and Jim Bear, PhD. Hockenberry is developing new microscopy methods so researchers can measure the mechanisms cells use to maneuver through tight spaces in the body.
February 29, 2024
Klaus Hahn, PhD, the Ronald G. Thurman Distinguished Professor of Pharmacology at the UNC School of Medicine, will co-lead this Chan Zuckerberg Initiative project with colleagues at Duke University and North Carolina State University.
February 29, 2024
In this new Vital Signs series, we feature graduate student Elizabeth Minor in the Ehre lab. Inspired by an immunology and cancer immunotherapy class during her time at the University of Virginia, Minor now studies viral challenges like SARS-CoV-2 and cystic fibrosis at the prestigious Marsico Lung Institute/UNC Cystic Fibrosis Center.
February 28, 2024
Under the direction of assistant professor of radiology Li-Ming Hsu, the research demonstrates how long-term cocaine use affects brain functions, making recovery and stifling cravings more difficult.
February 27, 2024
The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.